Janney Montgomery Scott’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.36M Sell
13,023
-1,900
-13% -$198K ﹤0.01% 1406
2025
Q1
$1.74M Buy
14,923
+1,178
+9% +$137K ﹤0.01% 1223
2024
Q4
$1.16M Buy
13,745
+6,546
+91% +$554K ﹤0.01% 1454
2024
Q3
$647K Buy
7,199
+1,569
+28% +$141K ﹤0.01% 1787
2024
Q2
$453K Sell
5,630
-150
-3% -$12.1K ﹤0.01% 1962
2024
Q1
$461K Buy
5,780
+500
+9% +$39.9K ﹤0.01% 2063
2023
Q4
$420K Sell
5,280
-280
-5% -$22.3K ﹤0.01% 2024
2023
Q3
$389K Buy
5,560
+1,073
+24% +$75.1K ﹤0.01% 1962
2023
Q2
$322K Buy
+4,487
New +$322K ﹤0.01% 2181
2023
Q1
Sell
-2,805
Closed -$216K 2527
2022
Q4
$216K Buy
+2,805
New +$216K ﹤0.01% 2327
2022
Q2
Sell
-5,722
Closed -$237K 2315
2022
Q1
$237K Sell
5,722
-327
-5% -$13.5K ﹤0.01% 1999
2021
Q4
$229K Buy
+6,049
New +$229K ﹤0.01% 2161
2021
Q3
Sell
-10,540
Closed -$711K 2287
2021
Q2
$711K Buy
10,540
+500
+5% +$33.7K ﹤0.01% 1443
2021
Q1
$568K Buy
10,040
+85
+0.9% +$4.81K ﹤0.01% 1484
2020
Q4
$811K Buy
9,955
+312
+3% +$25.4K ﹤0.01% 1284
2020
Q3
$687K Sell
9,643
-1,129
-10% -$80.4K ﹤0.01% 1270
2020
Q2
$886K Buy
10,772
+2,416
+29% +$199K 0.01% 1084
2020
Q1
$492K Sell
8,356
-14,004
-63% -$825K ﹤0.01% 1227
2019
Q4
$2.31M Sell
22,360
-6,115
-21% -$632K 0.02% 741
2019
Q3
$576K Buy
28,475
+950
+3% +$19.2K ﹤0.01% 1308
2019
Q2
$709K Buy
27,525
+9,950
+57% +$256K 0.01% 1223
2019
Q1
$250K Buy
+17,575
New +$250K ﹤0.01% 1748